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Despite evidence of augmented Natural Killer (NK) cell responses after influenza
vaccination, the role of these cells in vaccine-induced immunity remains unclear. Here,
we hypothesized that NK cells might increase viral clearance but possibly at the
expense of increased severity of pathology. On the contrary, we found that NK cells
serve a homeostatic role during influenza virus infection of vaccinated mice, allowing
viral clearance with minimal pathology. Using a diphtheria toxin receptor transgenic
mouse model, we were able to specifically deplete NKp46+ NK cells through the
administration of diphtheria toxin. Using this model, we assessed the effect of NK cell
depletion prior to influenza challenge in vaccinated and unvaccinatedmice. NK-depleted,
vaccinated animals lost significantly more weight after viral challenge than vaccinated
NK intact animals, indicating that NK cells ameliorate disease in vaccinated animals.
However, there was also a significant reduction in viral load in NK-depleted, unvaccinated
animals indicating that NK cells also constrain viral clearance. Depletion of NK cells
after vaccination, but 21 days before infection, did not affect viral clearance or weight
loss—indicating that it is the presence of NK cells during the infection itself that promotes
homeostasis. Further work is needed to identify the mechanism(s) by which NK cells
regulate adaptive immunity in influenza-vaccinated animals to allow efficient and effective
virus control whilst simultaneously minimizing inflammation and pathology.
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INTRODUCTION
Influenza viruses are a significant cause of respiratory tract infections, leading to seasonal epidemics
and unpredictable pandemics. Globally, influenza affects∼20–30% of children and 5–10% of adults,
resulting in 3–5 million cases of severe illness with up to 500,000 deaths, annually (1). The very
young, old, and immunocompromised are at greatest risk of succumbing to severe illness and death
(2). Currently, vaccination with live-attenuated or inactivated influenza virus is the most effective
method for reducing infections at both the individual and population level (3, 4).
Although adaptive immune responses play a key role in the resolution of influenza infection,
innate immune responses play an essential role in restricting virus replication and thus limiting
the scale of the initial infection (5). Amongst other innate immune players, Natural Killer (NK)
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cells can kill virus-infected cells and help to orchestrate nascent
adaptive immune responses (6). Defects in NK cells are associated
with increased susceptibility to viral infections (7, 8). NK
cell killing is mediated by cell surface cytotoxicity receptors
(such as the natural cytotoxicity receptors NKp30, NKp44,
and NKp46) binding to viral components or stress-induced
ligands on the surface of virus-infected cells, leading to directed
release of granzyme- and perforin-containing cytotoxic granules
and/or Fas/Fas-ligand interactions (9). Additionally, cytokine
(particularly interferon (IFN)-γ) production by NK cells plays an
integral role in shaping adaptive immunity (10, 11). For example,
NK-derived IFN-γ can activate dendritic cell migration, thus
promoting T cell priming (12). Evidence for the importance
of NK cells in influenza virus infection comes primarily from
studies in mice, although conclusions vary depending on the
precise model employed (Table S1). For example, depletion of
NK cells with anti-asialo GM1 antibody in mice and hamsters
resulted in increased morbidity and mortality from influenza
A virus infection (13). In addition, influenza infection is lethal
in mice lacking the NK cell specific receptor NKp46 (NCR1)
(14), which has been reported to be a receptor for the influenza
hemagglutinin (HA) protein (15, 16). Conversely, others have
reported that NK cell deficiency [whether through depletion
with anti-asialo GM1 or anti-NK1.1, or due to a lack of
interleukin (IL)-15] reduced weight loss and increased survival
(17–19). Moreover, little is known regarding the role of NK
cells in vaccine-induced immunity to influenza. We set out,
therefore, to address the role of NK cells during acute influenza
infection, before and after vaccination, using diphtheria-toxin
(DT) mediated ablation of NK cells in mice in which NKp46
expression drives co-expression of the DT receptor. Given that
IL-2 produced from influenza-specific T cells is dependent on
the NK cell driven IFN-γ response in early influenza infection
(11, 20), we hypothesized that NK cell ablation would impair viral
clearance and increase disease severity.
MATERIALS AND METHODS
Mice
C57BL/6J and C57BL/6-Gt(ROSA)26Sortm1(HBEGF)Awai/J mice
were purchased from Jackson Laboratories via Charles River
(Tranent, UK). C57BL/6-NKp46:iCre+/+ mice were kindly
provided by Professor Eric Vivier (Centre d’Immunologie de
Marseille-Luminy, Institut Universitaire de France, France).
C57BL/6-Rosa26iDTR+/+ and C57BL/6-NKp46:iCre+/+ mice
were crossed to generate F1 NKp46-iCre/Rosa26iDTR+/−
(referred to as NKp46-DTR). Groups of NKp46-DTR mice
were age- and sex-matched for all experiments, with influenza
challenge occurring between 8 and 10 weeks of age. Both sexes
of the F1 generation were used in this study, with 68 female and
106 male NKp46-DTR mice being used in total. The sexes of
mice used in each experiment are shown in the figure panels ({M}
male, {F} female) and figure legends. All mice were maintained in
individually ventilated cages in a specified pathogen free facility.
Viral Infection and Vaccination
Egg grown influenza A/California/4/2009 virus was kindly
provided by Dr. John McCauley (Crick Worldwide Influenza
Centre, The Francis Crick Institute, London UK) at 128
hemagglutination units (HAU)/mL and stored at −80◦C until
use. For infections, mice were anesthetized by intraperitoneal
(i.p.) injection of ketamine (100 mg/kg)/xylazine (10 mg/kg) and
then inoculated intranasally (i.n.) with 30 µL of virus (0.5 HAU)
diluted in Dulbecco’s phosphate-buffered saline (DPBS) (Gibco,
Loughborough UK). Mock-treated control mice were inoculated
similarly with DPBS. Mice were monitored and weighed daily to
assess infection and euthanized at day 4 post-infection (p.i.), or if
they reached the humane endpoint of 20% loss of body weight
at an earlier time point. Twenty eight days prior to challenge,
some mice were vaccinated by i.p. injection of the human 2015–
2016 seasonal influenza vaccine [human Sanofi-Pasteur-MSD
inactivated trivalent influenza vaccine (split-virion) containing
influenza haemagglutinin (HA), including A/California/7/2009
(H1N1) pdm09-like strain NYMC X-179A], diluted 1:3 in
DPBS with 500 µL per mouse with a final dose of 5 µg
of each HA.
Depletion of NK Cells
For selective depletion of NK cells, NKp46-diphtheria toxin
receptor (NKp46-DTR) mice were injected i.p. with 1.25 µg DT
(diluted in 100 µL DPBS) on days 25 and 28 post-vaccination.
Alternatively, mice were injected once with 2.5 µg DT and
allowed to recover for 3 weeks prior to influenza challenge.
Control (mock depleted) NKp46-DTR mice were injected i.p.
with 100 µL DPBS.
Isolation of Lung Cells and Viral
Supernatant
Lungs were aseptically removed from euthanized mice and
stored in 5mL DPBS on ice until processing. Lung single-cell
suspensions were obtained using methods previously described
(21). Briefly, isolated lungs were cut into 2–3 mm2 sections
and resuspended in 5mL digestion solution of Roswell Park
Memorial Institute (RPMI) 1640 Medium (Gibco) supplemented
with 5mM GlutaMax (Gibco), 5% (v/v) fetal bovine serum
(Gibco), and 1% (v/v) Penicillin-Streptomycin solution (10,000
units/mL, Thermo Fisher Scientific, Loughborough UK).
Digestion solutions contained DNAseI (20µg/mL) (Roche,
Basel Switzerland), and LiberaseTM (0.2 digestion units/lung)
(Roche). The lung suspensions were digested at 37◦C for 60min
with gentle rotating and then processed on a gentleMACS
dissociator (Miltenyi, Surrey UK). Lung homogenates were
then sieved through a 40µm nylon filter to remove debris (BD
Biosciences, Berkshire UK) and sieve washed with 5mL DPBS.
After centrifugation, an aliquot of lung supernatant was frozen
at −70◦C for downstream viral qPCR and IL-6 protein ELISA.
Cell pellets were then resuspended in 5mL ACK Lysis Buffer
(Lonza, Edinburgh UK), washed and resuspended with DPBS for
flow cytometry.
Flow Cytometry
Cells were stained in 96-well U-bottom plates as described
previously (22). Briefly, cell suspensions were stained with
antibodies to cell surface markers, fixed (Cytofix/Cytoperm;
BD Biosciences). Antibodies and dyes used for flow cytometry
staining are shown in Table 1. Cells were acquired on an LSRII
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flow cytometer (BD Biosciences) using FACSDIVA software.
Data were analyzed using FlowJo V10 (Tree Star). Gates were
initially set on singlets, followed by leukocytes (removing high
SSC-A and low FSC-A) and live cells. Subsequent gates were
based on unstained and/or FMO controls.
Viral Burden Determination
Influenza burden in lung-purified ribonucleic acid (RNA)
was determined by one-step quantitative reverse transcription
polymerase chain reaction (RT-qPCR) for the HA gene, as
previously described (23). RNA was isolated from 500 µL
of frozen lung cell supernatant (PureLink Viral RNA Mini
Kit, Thermo). As a standard, RNA was isolated from stock
virus (128 HAU/mL) and diluted 1:5 starting from 2.3 HAU
equivalents per well. Purified RNA (5 µL of 25 µL elution)
was mixed with 5 µL of TaqMan Fast Virus 1-step Master
Mix (Thermo), 7 µL of ultra-pure water, and 1 µL each of
forward primer SWH1-1080 (0.8µM, GATGGTAGATGGATG
GTACGGTTAT), reverse primer SWH1-1159 (0.8µM, TTG
TTAAGTAATYTCGTCAATGGCATT), and probe SWH1-1128
(0.25µM, FAM-AGGATATGCAGCCGACCT-NFQMGB) with
amplification conditions: 55◦C, 30min; 95◦C, 2min; 40 cycles
of 95◦C, 15 s and 60◦C, 30 s, on a 7900HT Fast RT-PCR system
(Applied Biosystems, Loughborough UK). For viral burden from
whole lung tissue, 500 ng of purified RNA (as reported below)
was assayed in the same manner as above.
RNA Analysis From Tissue
Whole lung tissue was stored in RNAlater (Ambion,
Loughborough UK) at post-mortem examination. RNA
was extracted from tissue using RNeasy extraction kit (Qiagen,
Manchester UK) according to the manufacturer’s instructions,
using a TissueRuptor probe (Qiagen) for tissue homogenization.
RNA was then treated with DNAseI (Ambion) to remove
genomic deoxyribonucleic acid (DNA) contamination. For a
quantitative analysis of messenger RNA (mRNA) levels, 1 µg of
total RNA from each sample was reverse transcribed in a 20 µL
volume (SuperScript IV VILO Master Mix; Thermo), and 2 µL
of complementary DNA (cDNA) was used for each real-time
reaction. RT-qPCR was performed using the primers listed in
TABLE 1 | Antibodies and dyes used for flow cytometry.
Antigen Clone
Zombie Aqua Dead/Live Not applicable
CD16.2 9e9
NKp46 (CD335) 29A1.4
CD19 6D5
CD3 145.2C11
CD11b M1/70
NK1.1 PK136
CD69 H1.2F3
CD107a 1D4B
Ly6C HK1.4
Ly6G 1A8
Table 2, SYBR green (Applied Biosystems) and 7500 Real-Time
PCR System (Applied Biosystems). Data were analyzed using the
comparative threshold cycle (cT) method (Applied Biosystems).
Target gene transcription of each sample was normalized to the
respective levels of beta-Actin mRNA and represented as fold
change over gene expression in control animals.
Plasma Analysis
Plasma was isolated by centrifugation of whole blood taken via
cardiac puncture into a heparinized syringe and stored at−70◦C.
Plasma IL-6 levels were determined by sandwich enzyme-linked
immunosorbent assay (ELISA) (Biolegend ELISA MAX Deluxe,
London UK). Values below the blank were reported at the limit
of detection for statistical purposes. To determine circulating
influenza HA antibodies following influenza vaccination, a
direct ELISA was done. Here, flat MaxiSorp 96-well plates
(Nunc) were coated overnight with the vaccine (diluted 1:3000
in DPBS, or 0.01µg/mL HA) or live virus (1.28 HAU/mL) at
100 µL. Using a commercial ELISA reagent kit (eBioscience
catalog number BMS412, Loughborough UK), plates were
washed three times and blocked for 1 h with 200 µL of assay
buffer. After washing, 100 µL of serially-diluted plasma was
incubated at room temperature (RT) for 2 h. After washing, 100
µL of sheep, anti-mouse immunoglobulin (Ig)-G horseradish
peroxidase (HRP)-linked secondary antibody (Amersham
catalog number NA931, GE Healthcare, Buckinghamshire UK)
diluted 1:4000 was incubated at RT for 2 h before final washes and
3,3’,5,5’-Tetramethylbenzidine (TMB) substrate development.
Absorbance was determined at 450 nm by SpectraMax M5
microplate reader (Molecular Devices, Wokingham UK).
Vaccine take was confirmed for all vaccinated mice with HA-IgG
ELISA at 1:100 dilution of plasma.
Histopathology
Sections were cut at 4µm thickness from formalin-fixed,
paraffin-embedded whole lung tissues and stained with
hematoxylin and eosin (H&E) by the University of Edinburgh
Easter Bush Pathology Laboratory and scored, in a blinded
fashion, for inflammation (vasculitis, bronchiolitis, and
alveolitis), oedema (perivascular oedema, peribronchiolar
TABLE 2 | Primers used for lung qPCR.
Gene Forward (Sense) Reverse (Antisense)
β-Actin AGAGGGAAATCGTGC
GTGAC
CAATAGTGATGACCTGGC
CGT
IL-6 GCACAACTCTTTTCTCAT
TTCCACG
GCCTTCCCTACTTCACAAG
TCCG
IFN-γ CAACAGCAAGGCGAAAAAG
GATGC
CCCCGAATCAGCAGCGAC
TCC
CXCL1 GCTTGCCTTGACCCTGAA
GCTC
TGTTGTCAGAAGCCAGCG
TTCAC
CXCL2 CGCCCAGACAGAAGTCAT
AGCCAC
TCCTTTCCAGGTCAGTTA
GCCTTGC
LCN2 ACATTTGTTCCAAGCTCC
AGGGC
CATGGCGAACTGGTTGTAG
TCCG
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oedema, and alveolar oedema), leukocyte infiltration
(perivascular, peribronchiolar, and in alveolar walls) and
neutrophil infiltration (perivascular, peribronchiolar, and
in alveolar walls). Each criterion was scored numerically as
unremarkable (0), mild (1), mild to moderate (2), moderate (3),
moderate to marked (4), and marked (5). Photomicrographs of
histological sections were taken using a 20× objective with an
Olympus BX41 microscope using an Olympus DP72 camera.
Statistical Analysis
Differences between groups were analyzed by Mann-Whitney U
test on compiled data from at least two independent experiments,
unless otherwise noted in legends. Further, data from each
independent experiment is shown as supplementary data in
Figures S1–S10. Spearman’s correlation was used to identify
statistically significant associations betweenweight loss, influenza
burden and lung neutrophils. P values above 0.1 are displayed
as “ns” (not significant) in the figures, with values below
0.05 considered significant. All analyses were conducted using
GraphPad Prism 7.
RESULTS
Influenza Vaccination Reduces Weight
Loss and Viral Burden in Mice
To characterize the role of NK cells in influenza infection
and immunization, we established a model of acute
influenza infection in C57BL/6J mice (Figure 1). C57BL/6J
mice were infected i.n. with 0.5 HAU of influenza strain
A/California/04/2009. Infected mice developed an acute
infection, losing 20% of their body weight by 4 days
post-infection (Figure 1A). Mice were also vaccinated,
intraperitoneally with the human Sanofi-Pasteur-MSD
inactivated trivalent influenza vaccine (split-virion), 4 weeks
prior to influenza challenge. Vaccinated mice lost significantly
less weight (Figure 1B) and had lower viral burden in their lungs
(Figure 1C) compared to unvaccinated mice; the reduction in
influenza burden in the lung correlated with reduced weight loss
(Figure 1D).
Acute influenza infection was marked by a significant
increase in the frequency of CD11b+ cells in the lung, with
a decrease in proportions of T (%CD3+) (Figure 1E, gating
Figure S12). The frequency of NK cells, identified by NK1.1 and
NKp46 co-expression (19, 24), did not change after influenza
infection (Figure 1E). However, there was a significant increase
in the side-scatter (SSC) of the NK cell population (Figure 1F,
gating Figure S13), indicating increased activation (25–27) and
expression of NKp46, an activating NK cell receptor reported
to bind influenza-derived HA (14, 28, 29), was also increased
in infected animals. Lastly, there was a significant increase in
the frequency of NK cell activation marker CD69 (Figure 1F).
Together, these results suggest that the immune response to acute
influenza infection, whether in a naïve or vaccinated animal,
is characterized by an influx of CD11b+ cells and activated
NK cells.
Depletion of NK Cells Prior to Influenza
Challenge Reduces Lung Virus Burden but
Increases Weight Loss in Vaccinated Mice
To evaluate the contribution of NK cells to vaccine-induced
protection from influenza infection, both male and female
transgenic mice (NKp46-DTR) were selectively depleted of NK
cells by injection of DT (Figure 2A) 3 days before infection. DT
treatment resulted in a robust depletion of NK cells from the lung
(Figure 2B, males, gating Figure S14, and females Figure S9) but
did not change circulating antibodies established by vaccination
(Figure S11, both sexes).
Depletion of NK cells prior to influenza challenge infection
led to a significant decrease in influenza burden in the lung
in vaccinated animals (Figure 2C, males). In pilot experiments,
the humane endpoint of 20% weight loss in unvaccinated mice
was reached by 6 days post infection (Figure 2D, females).
However, vaccinated animals lost only 5% of their body weight
and recovered to pre-infection weights by day 8 (Figure 2D).
Interestingly, vaccinated and infected animals which lacked NK
cells had prolonged weight loss which was more severe (10%)
than in NK cell-intact vaccinated mice (5%) and recovered to
baseline only by day 14 (Figure 2D). This exacerbated weight
loss of infected NK-depleted animals at 4 days post infection
compared to NK-cell sufficient mice was seen in both sexes
(Figure 2E, female, and Figure 2F, male).
No Change in Lung Inflammatory Cytokine
Response to Influenza Upon NK Cell
Depletion
Given that vaccinated NK cell-depleted animals lost more weight
than vaccinated NK cell-intact animals despite a lower viral
burden (Figure 2), we next looked at inflammatory markers
in the lung and plasma. In agreement with data from lung
supernatants (Figure 2C, males), viral burden determined
from whole lung RNA preparations was significantly lower
after NK cell depletion in unvaccinated animals, and not in
vaccinated animals (p = 0.08) (Figure 3A, females). While
Il6 and Ifnγ expression were increased with influenza
infection (Figure 3B), regardless of vaccination status
and viral burden (Figure 3A), transcripts of Il6 were not
significantly changed in NK cell depleted mice, while Ifnγ
showed a trend for a decrease in NK cell depleted mice
(Figure 3B).
Given that neutrophil influx into an influenza-infected
lung can enhance viral control (30), but can also contribute
to tissue damage through the release of extracellular traps
(31), we wondered whether increased neutrophil activity
in NK cell-depleted mice might explain our findings. We
therefore determined transcript levels of neutrophil chemokines
(Cxcl1, Cxcl2) and neutrophil secreted protein Lcn2 but
found no significant differences in transcript concentrations
between NK cell-deficient and NK cell-intact animals
(Figure 3C). Lastly, we assessed circulating levels of IL-6
[which have been implicated in neutrophil-mediated effects
(30)] and found no significant difference in plasma or
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FIGURE 1 | Primary influenza infection induces rapid weight loss and NK cell activation in lung but vaccination reduces weight loss and lung viral burden. (A) C57BL/6
female mice were challenged intranasally with 0.5 hemagglutination units (HAU) of influenza A/California/4/2009 (Flu) or mock treated with DPBS (Mock). Four weeks
prior to challenge, mice were vaccinated intraperitoneally with the trivalent Sanofi influenza vaccine (Vac). (B) Weight loss (mean ± SEM) over 4 days. (B–F) At day 4
post infection, lungs were excised and cell-free supernatant was analyzed by qPCR for influenza viral burden (plotted against a dose curve of Flu with known HAU,
giving HAU equivalents) (C) and plotted against weight loss (D). Data fitted to a non-linear regression line with R square value shown (D). (E,F) Lung cell pellets were
analyzed by flow cytometry for (E) cellular abundance and (F) Natural Killer (NK) activation markers. Data is compiled from two independent experiment (n =
5–11/group), with each independent experimental data shown in Figures S1, S2. Dots represent individual mice with bars showing mean. Significance determined by
Mann–Whitney U-test, ns, not significant.
lung supernatant IL-6 concentration in either vaccinated or
unvaccinated NK-depleted mice compared to NK cell-intact
mice (Figures 3D,E).
Influenza-Mediated Lung Pathology in
Vaccinated and NK Cell-Depleted Mice
Given the decreased viral burden but increased weight loss
upon influenza challenge in vaccinated NK cell-depleted
mice compared to NK cell-sufficient mice (Figure 2E, males
and 3A, females), we examined the lungs for histological
evidence of pathology. H&E stained lung sections were
assessed for pulmonary inflammation (vasculitis, bronchiolitis,
and alveolitis), edema (perivascular, peribronchiolar, and
alveolar), and infiltrating lymphocytes and neutrophils
(perivascular, peribronchiolar, and alveolar) (Figure 4, females;
see Datasheet 2 for individual mouse data). Influenza infection
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FIGURE 2 | NK cell depletion reduces lung viral burden and increases weight loss in vaccinated, influenza-challenged mice. Transgenic C57BL/6 mice with NKp46
driven expression of diphtheria toxin (DT) receptor were vaccinated 28 days prior to intranasal influenza (flu) challenge, as in Figure 1. (A) Immediately prior to
infection, a subset of mice received two intraperitoneal injections of DT (1.25 µg). (B) Levels of NK1.1+, NKp46+ NK cells in the lung, as a proportion of singlet, live
leukocytes at 4 days post infection (necropsy, nx). (C) At 4 days post infection, lung cell-free supernatants were analyzed by qPCR for influenza viral burden (plotted
against a dose curve of IFA with known HAU, giving HAU equivalents). (D) Weight loss (mean ± SEM) followed for 14 days post challenge, one experiment (n =
4–5/group) (E–F) Weight loss at day 4 post challenge. Data from males {M} (n = 9–10/group) is compiled from two independent experiments and females {F} (n =
9–13/group) from three independent experiments, with each independent experimental data shown in Figure S3. Dots represent individual mice with bars showing
mean. Significance determined by Mann–Whitney U-test, ns, not significant. *p < 0.05.
alone induces severe pathology (Figure 4). Interestingly,
while weight loss was more severe in vaccinated and
influenza challenged NK-depleted mice than in NK cell-
sufficient mice, pathological changes in the lungs were
significantly different only between unvaccinated and NK-
depleted mice—and not between vaccinated and NK-depleted
mice (Figure 4).
Finally, we measured the relative frequency of infiltrating
leukocytes and neutrophils in the lung by flow cytometry
(Figure 5, males). Influenza infection led to an infiltration of
CD3+ T cells (Figure 5A, gating Figure S15) into the lung
of NK-depleted mice, both CD4+ and CD8+ (Figure 5B).
Infection of unvaccinated mice was associated with an increase
in the frequency of activated (CD69+) T cells in the lung
(p = 0.006) (Figure 5C); this was attenuated by vaccination
(p < 0.001) and increased by depletion of NK cells. There
were no obvious effects of infection or vaccination on the
frequency of CD19+ B cell populations in the lung; the
modest apparent increase in B cell proportions in NK cell-
depleted mice (p = 0.02) may simply reflect distortion of cell
percentages by the absence of NK cells (Figure 5D, gating
Figure S16). However, given that influenza infection increases
the influx of CD11b+ cells into the lung (Figure 1D), we
further characterized influx of both inflammatory monocytes
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FIGURE 3 | NK cell depletion in vaccinated, influenza-challenged mice does not change inflammatory transcripts. Four days post infection in the model described in
Figure 2A, (A) Lung RNA was analyzed by qPCR for influenza viral burden (plotted against a dose curve of influenza with known HAU, giving HAU equivalents per 5
µg RNA tested). (B,C) Transcript levels of inflammatory cytokine genes (B) Il6 and Ifnγ and (C) neutrophil-related chemokines Cxcl1 and Cxcl2, along with neutrophil
lipocalin protein (Lcn2). RNA induction normalized to housekeeping gene β-actin and displayed as induction over mock-treated control mice. (D) Plasma levels of IL-6
(pg/mL). (E) IL-6 levels in lung supernatants after whole lung enzymatic digestion for single cell isolation and viral burden quantification. Data from females {F} (n =
5–9/group) and males {M} (n = 7–10/group) is compiled from two independent experiments, with each independent experimental data shown in Figures S4, S5.
Dots represent individual mice with bars showing mean. Significance determined by Mann–Whitney U-test, ns, not significant.
(%Ly6C-high) and neutrophils (%Ly6G+) in the lungs of NK-
depleted mice. The modest reduction in leukocyte infiltration
in the lung that was evident from histology (Figure 4), was
reflected in reduced infiltration of inflammatory monocytes
into the lung in unvaccinated NK cell-sufficient animals
compared to NK-depleted animals (Figure 5E), but there
was no additional effect of combining vaccination and NK
cell depletion. Neutrophil infiltration into the lung was also
increased with NK cell depletion, with the frequency of Ly6G+
polymorphonuclear cells being significantly higher in both
vaccinated and unvaccinated influenza-infected NK cell-depleted
mice compared to NK cell sufficient mice (Figure 5F). A single
experiment in female mice also found a trend for an increase
in Ly6G+ neutrophils in vaccinated and NK cell-depleted mice
(Figure S9). Taken together, these data suggest that the increased
weight loss observed with influenza infection in NK cell-depleted
vaccinated mice compared to NK cell intact vaccinated mice
may be due, in part, to failure of NK cell-depleted mice
to control cellular infiltration into the lungs, despite reduced
viral burden.
Depletion of NK Cells After Vaccination,
and Subsequent Repopulation, Does Not
Alter the Response to Influenza Challenge
in Mice
To determine if the effects of NK cell depletion on post
vaccination immunity to influenza were mediated by NK cells
present at (and potentially affected by) vaccination (32), we
depleted NK cells (by a single treatment with 2.5 µg of DT)
3 weeks after influenza vaccination (as previously) but then
waited another 3 weeks before challenging the mice (to allow
repopulation) (Figure 6A). NK cells were initially (after 3 days)
very effectively depleted by the DT treatment and, as predicted,
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FIGURE 4 | NK cell depletion in vaccinated, influenza-challenged mice does not alter pathology. Four days post infection in the model described in Figure 2A, whole
lungs were excised, stored in 10% formalin, and embedded on paraffin for hematoxylin and eosin staining. Pathology was scored for: (A) Inflammation (vasculitis,
bronchiolitis, and alveolitis), Edema (perivascular, peribronchiolar, and alveolar), Leukocytes and Neutrophils (in perivascular space, peribronchiolar space, and alveolar
wall). Full scoring details in Supplementary Files. Pathology scores from females {F} (n = 4–8/group) is compiled from two independent experiments, with each
independent experimental data shown in Figure S6. Dots represent individual female {F} mice with bars showing mean. Significance determined by Mann–Whitney
test, ns, not significant. (B) Representative photomicrographs of pathological changes observed. Arrows, bronchiolitis with exudates in bronchiolar lumina.
*Perivascular and peribronchiolar edema. Scale bar in mock equals 50µm.
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FIGURE 5 | NK cell depletion in vaccinated, influenza-challenged mice increases lung CD3+ T cell and neutrophil infiltration. Four days post infection in the model
described in Figure 2A, whole lungs were excised and single cells isolated for flow cytometry. Proportion (%) of (A) CD3+ T cells, (B) CD3+CD4+ and CD3+CD8+ T
cells, and (C) active (CD69+) CD3+ T cells, as determined from singlet, live lung leukocytes. Proportion (%) of (B) CD19+ B cells, (C) Ly6C-high inflammatory
monocytes, and (D) Ly6G+ neutrophils. Data in (A) from males {M} (n = 7–14/group) is compiled from three independent experiments and data in (B–F) from males
{M} (n = 7–10/group) is compiled from two independent experiments, with each independent experimental data shown in Figure S9. Dots represent individual mice,
with bar representing mean. Significance determined by Mann-Whitney U test, ns, not significant.
the NK cell compartment did partially recover by the time of
influenza challenge (Figure 6B). In this case, removal of NK
cells present at vaccination and subsequent NK cell repopulation
resulted in influenza infections that were not significantly
different from those in intact mice, with no significant differences
in disease severity (weight loss; Figure 6C), lung viral load
(Figure 6D) or circulating IL-6 concentrations (Figure 6E). This
experiment suggests that the effects of NK cell depletion on post
vaccination immunity are due to the lack of all NK cells, rather
than a lack of NK cell populations that were primed or activated
by vaccination.
DISCUSSION
The key findings of this study, summarized in Figure 7, are
that: (1) influenza vaccination is effective in reducing viral
burden and weight loss in mice; (2) in both vaccinated and
unvaccinated mice, NK cells ameliorate disease (weight loss) at
the expense of delaying viral clearance; (3) that the magnitude of
the effect on disease is greater in vaccinated than unvaccinated
mice (2.5-fold greater weight loss vs. 1.11-fold, respectively),
and (4) the depletion of any “memory” NK cells that might
have been induced by vaccination did not alter the response
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FIGURE 6 | Depletion of NK cells after vaccination, and subsequent repopulation, does not alter lung viral burden, disease severity or systemic inflammation after
challenge. (A) Transgenic C57BL/6 mice with NKp46 driven expression of diphtheria toxin (DT) receptor were vaccinated 42 days (d) prior to intranasal influenza (Flu)
challenge and treated with DT (NK-depleted) 21 days prior to challenge with necropsy (nx) at 4 days post influenza challenge. (B) At 3 and 21 days post DT treatment,
lungs were excised and single cells isolated for flow cytometry for the proportion (%) of NK1.1+, NKp46+ NK cells. (C)Weight loss at 4 days post influenza challenge.
(D) Lung cell-free supernatants were analyzed by qPCR for influenza viral burden (plotted against a dose curve of Flu with known HAU, giving HAU equivalents). (E)
Plasma levels of IL-6 (pg/mL). Data from males {M} (n = 4–10/group) is compiled from two independent experiments, with each independent experimental data
shown in Figure S10. Dots represent individual mice with bars showing mean. Significance determined by Mann-Whitney test, ns, not significant.
FIGURE 7 | Summary model of role of NK cells in influenza vaccination and challenge. (A) Influenza virus infection in naïve mice results in an influx of inflammatory
monocytes (Ly6Chigh) into the lung, with evident histopathology and rapid weight loss. (B) Vaccination reduces lung virus load and associated pathology (weight loss).
(C) In unvaccinated animals, NK cell depletion reduces viral load and associated inflammation after influenza infection compared to NK cell replete animals, but
animals still lose a significant amount of weight. (D) NK depletion of vaccinated mice further reduces influenza viral load and weight loss after infection, yet pathology
scores are similar to those of NK intact mice. However, vaccination combined with NK depletion is accompanied by an increase in infiltration of neutrophils and
activated T cells into the lung after influenza infection, suggesting that NK cell depletion enhances the control of virus replication as a result of enhanced adaptive
immunity but that this comes at the price of significantly increased morbidity. Model created with BioRender.
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to influenza virus in vaccinated mice. These data suggest that
NK cells play an important homeostatic role, allowing influenza
virus to be controlled without causing severe disease, and that
this effect is enhanced by vaccination—indicating a role for
NK cells in regulating the adaptive immune response. Our
study therefore supports previous data suggesting an important
role for NK cells in moderating adaptive immune effector
mechanisms (33).
Previous work has suggested that the role of NK cells
during influenza infection is dependent on the infecting dose
of the virus, with NK cells being protective during low dose
infection (0.5 HAU) and pathogenic during high dose infection
(5 HAU) (19). Although we used the A/California/4/2009
strain of influenza rather than PR8 strain used by Zhou
et al. we used an infecting dose that is similar to the low
dose used by Zhou et al. (0.5 HAU) and saw a similar
trend. Interestingly, an opposite effect was seen during murine
cytomegalovirus (MCMV) infection where NK cells prevented
pathology at high viral doses but enhanced disease at low
doses (34).
Although we saw a clear impact of NK cell depletion on the
post-vaccination response to influenza in both male and female
mice, we did observe some sex-specific differences in our data.
Whilst we do not have a complete, replicated set of all data
in both sexes at every time point, limiting our ability to draw
specific conclusions regarding the impact of sex on the role of NK
cells during influenza infection and vaccination, we found that
NK cell-depleted unvaccinated male mice (but not female mice)
lost significantly more weight than intact mice after infection
(Figures 2E,F) despite the two sexes having similar viral loads.
We also observed that female mice generated higher titres of
neutralizing antibodies after influenza challenge (Figure S11C),
confirming previous work with PR8 virus by Lorenzo et al. (35).
Sex differences in response to influenza infection and influenza
vaccination have been noted in mice and in humans [reviewed
by (36)] however, many previous studies to determine the role
of NK cells during acute influenza infection mice have used
male or female mice only, or have failed to define the sex
of the mice used (Table S1). Future work should consider the
impact of sex on the role of NK cells during a recall response to
viral infection.
The mechanisms by which NK cells moderate adaptive
immune responses are not fully understood. Our observation
that NK cell depletion tended to increase neutrophil influx
into the lungs of influenza infected mice, and significantly
increased neutrophil accumulation in lungs of vaccinated mice,
suggests that NK cells may serve to limit neutrophil migration
to sites of infection. This would be in line with studies showing
that neutrophils are important in controlling influenza virus
infection (37–39) but can contribute to severe pulmonary
pathology (40–42).
Another possibility is that NK cells regulate the accumulation
of adaptive, cytotoxic (CD8+) effector T cells at the site of
infection, thereby reducing tissue damage but slowing viral
clearance. In RSV infection, for example, CD8+ cells are
directly associated with weight loss and depleting them reduces
disease (43). NK cells have been shown to eliminate activated
CD4+ and CD8+ T cells in different model systems (33, 34,
44), mediated by either perforin or TNF-related apoptosis-
inducing ligand (TRAIL) (45, 46). However, thus far, in influenza
vaccination models CD8+ T cells appear to contribute to both
reduced viral load and reduced disease severity (47). Due to
limitations of cell numbers, we were unable to characterize
the responsiveness of T cells in this study and therefore
further work is needed to determine whether the lack of NK
cells removes the brake on adaptive T cell responses during
influenza infection.
In a recent study (48), murine NK cells licensed on self MHC
were shown to localize to infected lung tissue and produce IFN-γ
after influenza A (strain PR8) infection. Unlicensed NK cells, in
contrast, were enriched in draining (mediastinal) lymph nodes,
produced GM-CSF and promoted dendritic cell infiltration and
CD8+ T cell responses. It is therefore likely that distinct subsets
of NK cells may selectively promote inflammation or antiviral
immunity. Furthermore, this may differ depending on levels of
adaptive immunity.
In humans, memory-like NK cells can be generated by
cytokine or influenza virus pre-activation; these cells show
enhanced responses to cytokines or influenza virus upon re-
stimulation (11, 32, 49). It is conceivable that prior activation
of NK cells, for example by vaccine-induced inflammatory
cytokines, could influence the migration and function of these
cells upon viral challenge. Certainly, human nasal challenge
with Fluenz induces a local (nasal mucosal) innate cytokine
signature with potential NK cell activating capacity (50).
Nevertheless, we wondered whether a similar phenomenon
might also be apparent in this mouse model (where more
precise dissection of the underlying local mechanism of NK
cell enhancement might be possible). Therefore, we depleted
NK cells immediately after vaccination (thus removing any
putative “memory” NK cells, defined as cells with altered
function after prior exposure), and rested the mice for 3
weeks to allow repopulation before challenging with influenza
virus. We observed no differences in the outcome of influenza
infection between these NK cell-depleted/repopulated vaccinated
mice and intact, vaccinated mice. These data suggest that
“memory” NK cells are not induced by influenza vaccination
in mice or that any such cells are no more effective at
moderating adaptive responses to influenza than are “naïve”
NK cells.
In mice, cytokine-induced memory-like NK cells can
be adoptively transferred and maintained by homeostatic
proliferation (51) and work by Li et al. has demonstrated that
NK cells generated in the liver following primary infection
can reduce influenza viral burden in the lung upon secondary
challenge in Rag1-deficientmice (52). However, to date, memory-
like NK cells have not been demonstrated after influenza
vaccination and the contribution of either tissue-resident or
blood-derived “memory” NK cells during a robust recall
response in B/T-cell intact mice has yet to be characterized. In
addition, human studies have been limited to peripheral blood
and further investigations are needed to test how NK cells
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influence inflammatory cellular infiltrates at the site of virus
infection. Vaccination and challenge studies (with local mucosal
sampling for virus, cellular infiltrates and cytokine production)
are now needed to reveal the impact of vaccine-induced NK
cell priming and “memory” generation on virus replication
and pathology.
There are some important caveats to keep in mind, however.
Firstly, in contrast to previous studies usingmice lacking NK cells
at the time of infection or vaccination, or depleted of NK cells
with antibodies on animals of different sexes (Table S1), we used
an inducible, endogenous method of NK cell depletion which
may have fewer limitations (24). Nevertheless, DT treatment
alone lead to some limited weight loss and pulmonary pathology,
likely due to death of ∼15% of lung leukocytes, although there
was no induction of inflammatory cytokines nor any influx of
immune cells into the lung. It remains a possibility, therefore,
that the mild inflammation induced by NK cell depletion may
have affected the outcome of the experiments. Further, sex
differences in influenza-mediated lung pathology have been
noted (36). Secondly, the ethically-approved humane end point
for our study was deemed to be 20% weight loss (after which
animals were euthanized), essentially precluding determination
of long-term survival after NK cell depletion but some studies
have shown only limited correlation between weight loss and
long term survival (18), with viral challenge dose a greater
predictor of survival despite similar weight loss kinetics (19). A
further caveat of the Rosa-DT conditional “NK cell” depletion
system used here is a potential parallel depletion of mature
NKp46+ ILC1 and ILC3 cells (53). Studies in deficient ncr1gfp
mice, which are susceptible to lethal influenza A infection,
demonstrate systemic loss of ILC1, whilst maintaining NKp46
negative NK cell subsets (14, 54). Although rare in the non-
pathologic lung, our studies do therefore not exclude a potential
contribution of ILC-1s to inflammatory processes after influenza
vaccination or challenge infection. Lastly, characterization of
cytokine protein levels in the bronchoalveolar lavage fluid would
be beneficial in understanding transcriptional changes observed
in this study.
To summarize, we have demonstrated that NK cells play a
homeostatic role in adaptive immunity to influenza infection
in mice. While the precise mechanism by which NK cells
modulate adaptive immunity remains unclear, their presence
is crucial for resolving infection with minimal immune
pathology. Further studies to determine the mechanism(s)
at play may inform the design of safer and more effective
influenza vaccines.
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